DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Specialty Pharmacy has expanded its limited distribution drug (LDD) network to now include 265 products, placing it among the leading networks in specialty pharmacies. LDDs are specialty medications that are available through select specialty pharmacies chosen by the drug manufacturer and are often medications with complex regimens, high costs and/or require special handling. As the largest independent specialty pharmacy not directly affiliated with a
Related Questions
How will the expanded LDD network affect Walgreens' specialty pharmacy revenue and margins?
What is the competitive landscape for limited distribution drugs and how does Walgreens' network size compare to rivals like CVS and Amazon?
Will this expansion drive a measurable change in WBA's stock price or valuation multiples in the near term?